光莆股份(300632.SZ)控股股東承諾3個月內不減持
格隆匯12月24日丨光莆股份(300632.SZ)公佈,公司於近日收到了公司控股股東林瑞梅、林文坤分別出具的《關於不減持廈門光莆電子股份有限公司股份的承諾函》。
林瑞梅和林文坤自願承諾:即日起3個月內(即2020年12月23日至2021年3月22日),本人不以任何方式減持本人所直接持有的光莆股份的股票,包括承諾期間該部分股份因資本公積轉增、派送股票紅利、配股、增發等事項產生的新增股份。
截止該公告披露日,林瑞梅直接持有公司股份6980.1022萬股,佔公司總股本的22.72%;林文坤直接持有公司股份6954.1491萬股,佔公司總股本的22.64%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.